- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03674645
Test and Optimization of New Specific MRI Sequences on an Imager Dedicated to Research (SEQ-IRM)
February 9, 2022 updated by: University Hospital, Bordeaux
Magnetic Resonance Imaging (MRI) performance depends on equipment performance, equipment maintenance and relevance of MRI sequence used.
To optimize MRI performance, it's necessary to develop, optimize, test and validate new acquisition sequences for enhanced diagnosis and therapy monitoring.
These new sequences will allow better spatial resolution and specificity while reducing acquisition time.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The purpose of the present study is to test and optimize, on healthy subjects, specific MRI acquisition sequences firstly developed in a preclinical phase on phantoms (inert objects containing solutions or gels) and animal (Pig, sheep).
This study will allow the investigators to define practical acquisition parameters that will allow reproducible results and precise definition of clinically relevant examination protocols for each new developed sequence.
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hubert COCHET, MD
- Phone Number: +33 (0)557675613
- Email: hubert.cochet@chu-bordeaux.fr
Study Contact Backup
- Name: Lorena SANCHEZ BLANCO, MD
- Phone Number: +33 (0)557623091
- Email: lorena.sanchez-blanco@chu-bordeaux.fr
Study Locations
-
-
-
Pessac, France, 33604
- Recruiting
- CHU de Bordeaux
-
Contact:
- Hubert COCHET, MD
- Phone Number: +33 (0)557675613
- Email: hubert.cochet@chu-bordeaux.fr
-
Contact:
- Lorena SANCHEZ BLANCO
- Phone Number: +33 (0)557623091
- Email: lorena.sanchez-blanco@chu-bordeaux.fr
-
Principal Investigator:
- Hubert COCHET, MD
-
Sub-Investigator:
- Bruno QUESSON
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy volunteers (over 18 yo),
- Male or female,
- Affiliated to social security,
- Without any contraindication to MRI exam and who will have signed a written inform consent.
Exclusion Criteria:
- Individuals deprived of liberty,
- Under guardianship or curatorship,
- Persons with known disease which could disturb MRI acquisition or with absolute or relative contraindication to an MRI examination
- Pregnant women,
- Breastfeeding women,
- Women without effective contraception,
- Participants who refused to be informed of the possible discovery of a significant anomaly,
- Persons involved in an interventional study with a drug or an implantable device.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: MRI
MRI exam performed on 200 healthy volunteers
|
Procedure of the study is an MRI exam without any injection or invasive procedure, that will be performed on the Siemens Magnetom Aera imager of Liryc institute (L'Institut de RYthmologie et modélisation Cardiaque) (Xavier Arnozan site - Bordeaux)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Image quality
Time Frame: Day 0
|
Day 0
|
|
Signal to noise ratio
Time Frame: Day 0
|
Day 0
|
|
Contrasts between structurally different regions
Time Frame: Day 0
|
The values of the signal intensities will be measured in adjacent structures of interest.
The difference between these values divided by the noise will be calculated to quantify the contrast-to-noise ratio between these structures.
The higher this value is, the better is the sequence in its ability to differentiate these structures from one another.
|
Day 0
|
Total acquisition time
Time Frame: Day 0
|
Day 0
|
|
Qualitative interpretation of image quality to respiratory and cardiac motions
Time Frame: Day 0
|
In the presence of improper compensation for cardiac and / or respiratory movements, the images may appear blurred.
The qualitative interpretation of image quality will be performed by visual image analysis.
|
Day 0
|
Quantitative interpretation of image quality to respiratory and cardiac motions
Time Frame: Day 0
|
In the presence of improper compensation for cardiac and / or respiratory movements, the images may appear blurred.
The quantitative interpretation of image quality will be performed by a measurement of sharpness of contours between adjacent structures of interest.
|
Day 0
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hubert COCHET, MD, University Hospital, Bordeaux
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 19, 2018
Primary Completion (Anticipated)
September 1, 2023
Study Completion (Anticipated)
September 1, 2023
Study Registration Dates
First Submitted
August 20, 2018
First Submitted That Met QC Criteria
September 14, 2018
First Posted (Actual)
September 17, 2018
Study Record Updates
Last Update Posted (Actual)
February 10, 2022
Last Update Submitted That Met QC Criteria
February 9, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CHUBX 2017/21
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Magnetic Resonance Imaging Sequences
-
BayerCompletedMagnetic Resonance Imaging | Magnetic Resonance AngiographyPoland, China, France, Germany, Hungary, Korea, Republic of, South Africa, Spain, Thailand, Taiwan, Czech Republic, Hong Kong, Italy, Kazakhstan, Russian Federation, Bosnia and Herzegovina, Greece, Canada, Vietnam, Kyrgyzstan
-
Centre Hospitalier Régional Metz-ThionvilleUniversity of LorraineRecruitingMagnetic Resonance ImagingFrance
-
Jessa HospitalActive, not recruitingMagnetic Resonance ImagingBelgium
-
BayerCompletedMagnetic Resonance ImagingUnited States, Korea, Republic of, France, Germany, Italy, Switzerland, United Kingdom
-
Boston Scientific CorporationCompletedMagnetic Resonance ImagingSpain, Hong Kong, Germany, Israel, United Kingdom, Italy, United States, Malaysia, Belgium
-
Centre Hospitalier Universitaire, AmiensCompletedMagnetic Resonance ImagingFrance
-
MegaPro Biomedical Co. Ltd.CompletedMagnetic Resonance ImagingTaiwan
-
BayerCompletedMagnetic Resonance ImagingJapan
-
BayerCompletedMagnetic Resonance ImagingPhilippines
-
BayerCompletedMagnetic Resonance Imaging | Myocardial Perfusion ImagingSwitzerland, Germany, Austria, Poland
Clinical Trials on MRI acquisitions
-
Centre Hospitalier Universitaire, AmiensHôpital Edouard HerriotRecruitingMagnetic Resonance Imaging | Transplantation | Radial Artery | Vascular ComplicationsFrance
-
Philips Electronics Nederland B.V. acting through...CompletedPregnancy RelatedFrance
-
Rennes University HospitalNational University of Ireland, Galway, Ireland; European Union; Tampere University... and other collaboratorsActive, not recruiting
-
Centre Hospitalier Universitaire de Saint EtienneUniversité Jean Monnet, Saint-Étienne, France.; Laboratoire EA SNA=EPIS 4607.Terminated
-
Centre Hospitalier Régional d'OrléansCompletedCardiac FunctionFrance
-
University Hospital, ToulouseInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedDelirium | Covid19 | Post-traumatic Stress DisorderFrance
-
Hospices Civils de LyonNot yet recruiting
-
Institut Claudius RegaudLaboratoire IJCLabNot yet recruiting
-
Centre Hospitalier Universitaire, AmiensCompleted
-
Cambridge University Hospitals NHS Foundation TrustRecruitingBreast CancerUnited Kingdom